Related Experiment Video

Updated: Jul 8, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Are comorbidity indices useful in predicting all-cause mortality in Type 2 diabetic patients? Comparison between

Matteo Monami1, Lorella Lambertucci, Caterina Lamanna

  • 1Unit of Gerontology and Geriatrics, Department of Critical Care Medicine and Surgery, University of Firenze, Firenze, Italy. mmonami@libero.it

Aging Clinical and Experimental Research
|January 4, 2008
PubMed

Insights

A simple disease count effectively predicts mortality in type 2 diabetes patients, similar to the Charlson Comorbidity Index. This finding offers a simpler approach for assessing risk in diabetic populations.

Area of Science:

  • Endocrinology
  • Gerontology
  • Public Health

Background:

  • Comorbidity significantly impacts general population morbidity and mortality.
  • Limited research exists on comorbidity index validity specifically in diabetic patients.
  • Predicting outcomes in type 2 diabetes (T2D) requires robust assessment tools.

Purpose of the Study:

  • To compare the predictive accuracy of disease count versus Charlson's Comorbidity Index (CCI) for 3-year mortality in T2D patients.
  • To evaluate the utility of simple comorbidity measures in a diabetic cohort.

Main Methods:

  • A cohort of 1667 T2D outpatients was studied.
  • Comorbidity was assessed using disease count and Charlson's index.
  • All-cause mortality data were collected over a 3-year follow-up period.

Main Results:

  • The 3-year mortality rate was 11.9% (4.7% yearly).
  • Each additional disease independently increased mortality by 54%.
  • Each CCI point increased mortality by 31%.

Conclusions:

  • Disease count demonstrates comparable predictive value for mortality in T2D patients as the CCI.
  • Simple comorbidity assessment is valuable in T2D outcome prediction.
  • Further research is needed on specific comorbidity indices for predicting disability in diabetics.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...